Skip to main content
Fig. 6 | Biomarker Research

Fig. 6

From: Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma

Fig. 6

Prognostic value of frequently mutated genes for patients with ENKTCL. a Immunohistopathology staining of KMT2D in patients with mutated KMT2D and wild type, scale bar, 25 μm. Kaplan-Meier estimated OS with the plasma KMT2D (b), ATM (c), APC (d), ASXL3 (e), JAK3 (f), SETD2 (g) mutation status in patients with ENKTL, and plasma EBV-DNA levels (h)

Back to article page